[Antiangiogenic therapy for types I and II macular neovascularization in age-related macular degeneration].
Maria BudzinskayaA V ShelankovaA A AndreevaAnna A PlyukhovaM A AfanasyevaPublished in: Vestnik oftalmologii (2021)
Antiangiogenic therapy has shown good functional and morphological effectiveness in both first and second types of MNV.